TGTripti Gupta

Tripti Gupta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tripti Gupta has a total of 153 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Navigating the Road to Specialization in Adult Congenital Heart Disease

    by Tripti Gupta, Rawan Amir, Benjamin P Frischhertz, Daniel Clark, Christopher R Broda, Jeannette Lin, Jamil A Aboulhosn, Joshua Saef

    Adult congenital heart disease (ACHD) has evolved from a pediatric-focused field to a growing adult cardiovascular subspecialty, driven by advances in surgery and medical therapy that now allow nearly 2 million adults in the United States to live with congenital heart disease. Despite these advances, an estimated workforce of board-certified ACHD cardiologists remains insufficient for the growing patient population, underscoring a continued mismatch between workforce needs and the trainee pipeline. This manuscript reviews contemporary pathways to ACHD sub-specialization, including a combined internal medicine and pediatrics (‘Med-Peds’) residency followed by adult or pediatric cardiology, internal medicine followed by adult cardiology, and pediatrics followed by pediatric cardiology, each culminating in dedicated ACHD fellowship. For each route, the article outlines key strengths, limitations, and typical curricular emphases, and describes how Accreditation Council for Graduate Medical Education-recommended clinical blocks can be tailored to remediate background-specific gaps while preserving a common competency-based endpoint. By clarifying training structures, expectations, and career implications, this work seeks to demystify the pathway to ACHD cardiology and encourage workforce interest in caring for this rapidly growing, high-need population.

  • Open Access

    Common Clinical Scenarios in Adult Congenital Heart Disease: A Practical Guide for General Cardiologists

    by Tripti Gupta, Matthew R. Carazo

    Adults with congenital heart disease (ACHD) represent a growing population of adults in the United States, necessitating lifelong care by ACHD specialists. Often, patients may be lost to follow-up after pediatric care or elude detection until adulthood, presenting to the emergency room with common clinical complaints such as chest pain, dyspnea on exertion, or palpitations. This review demystifies common clinical presentations in pulmonary stenosis, branch pulmonary stenosis, coarctation of the aorta, and subaortic stenosis and their associated pathophysiology, salient clinical features, multimodality diagnostic findings, and indication for intervention.

  • Open Access

    From Insight to Action: A National Patient‐Centered Strategic Framework for Improving Reproductive Health Outcomes in Individuals With Congenital Heart Disease

    by Mindi Messmer, Tripti Gupta, Rohan D'SOuza, Melissa Russo, Jamie L. Jackson, Kashvi Singh, Katherine B. Salciccioli, Katia Bravo‐Jaimes, Nadine A. Kasparian, Ayesha Abusbeitan, et al.

    Background: An increasing number of patients with congenital heart disease (CHD) are pursuing pregnancy with the potential for cardiovascular complications. This study aimed to establish patient‐centered national research and care priorities to improve pregnancy‐related outcomes for individuals with CHD. Methods: This mixed‐methods study used a modified Stakeholder Engagement in Question Development methodology to systematically identify patient‐centered priorities. Key activities included consortium engagement (phase 1), patient and provider questionnaires (phase 2), and an in‐person facilitated meeting to explore survey results and follow‐up virtual focus groups (phase 3). Reflexive thematic analysis was used to synthesize short‐ and long‐term research priorities (phase 4). Results: Three overarching goals emerged: (1) improving access to specialized CHD, cardio‐obstetrics, and mental health care; (2) improving quality and consistency in clinical care; and (3) increasing patient and community engagement. These goals were then expanded into 5 central themes: (1) communication within the health care setting; (2) community engagement; (3) ancillary clinical support; (4) integration of patient‐reported outcomes; and (5) implementation, education, and knowledge mobilization. Short‐term (1–5‐year) goals included expanded telemedicine use, best practice recommendations for multidisciplinary care coordination, and targeted educational resources. Long‐term (5–10‐year) goals included expansion of adult CHD and cardio‐obstetrics programs, integration of mental health services, and advocacy to improve insurance coverage. Conclusions: The consortium provided a national, community‐driven prioritization that highlights actionable pathways to improve pregnancy outcomes for people with CHD. Sustained engagement with patients and community partners is essential to achieving durable improvements across cardio‐obstetric care, education, research, and mental health.


  • Open Access

    Single organ transplant for transposition of the great arteries

    by Tripti Gupta, Kayla Buttafuoco, Kara Siegrist, Kelly Mishra, Benjamin Byrd, Frank Fish, Angela Weingarten, Benjamin Frischhertz, Roman Perri, Martin Montenovo, et al.

  • Open Access

    Cardiac resynchronization therapy among adults with a systemic right ventricle: a multicenter experience

    by Flavia Fusco, Giancarlo Scognamiglio, Mikael Dellborg, Payam Dehghani, Susan M. Jameson, W. Aaron Kay, Jonathan W Cramer, Isabelle Vonder Muhll, Eric V. Krieger, Fred Rodriguez, et al.

    Background: Cardiac Resynchronization Therapy(CRT) is a key treatment for heart failure (HF) in acquired heart disease, but its benefits in adults with congenital heart disease and a systemic right ventricle (sRV) remain unclear. This study aimed to assess whether CRT improves outcomes in patients with sRV. Methods: This analysis was part of an international, retrospective study of data from 33 centers including patients >18years with transposition of the great arteries (TGA) following atrial switch operation and congenitally corrected TGA (ccTGA). The primary endpoint was overall survival. The secondary endpoint was a composite of death, hospitalization for HF, heart transplant, mechanical support, ventricular tachycardia/ICD therapies. Results: We identified 105 out of 1,721 patients(3.5%) who underwent CRT. Median follow-up after CRT implant was 4.6 [1.6-8] years. There was no overall QRS improvement (157±37 Vs 153±31 ms; p=0.2), which was limited to those with previous pacing (167±35 Vs 154± 28 ms; p=0.002). Following CRT, there was no significant change in B-type natriuretic peptide values, peakVO 2 , tricuspid regurgitation severity by echocardiography. CRT complications occurred in 10 (9.5%), though there were usually minor. Patients with CRT were propensity-matched to controls according to age, sex, morphology (ccTGA/TGA), presence of complex disease, previous HF admission and sRV dysfunction at baseline. At univariable analysis, CRT (OR 4.02-95% CI:1.48-10.89; p=0.006), older age, and moderate to severe sRV dysfunction at baseline were predictive of death. By multivariable analysis, CRT (OR 2.1-95% CI:1.2-3.8; p=0.008), age (OR 1.03-95% CI:1.01-1.06; p=0.001) and moderate to severe sRV dysfunction (OR 2.5-95% CI:1.3-4.4; p=0.002) were independently associated with poorer outcome. After matching using only patients with subpulmonary ventricle pacing as controls, overall survival was still worse in CRT group (p=0.0057). Conclusion: In this retrospective study in the largest population thus far described with a sRV, CRT implant was not associated to improved survival, even after controlling for key confounders. Further studies with randomization are required to improve the selection of candidates with a sRV most likely to derive benefit from CRT, elucidate the optimal timing, and assess alternative strategies.


  • Pregnancy care experiences for adults with congenital heart disease in the United States

    by Tripti Gupta, Mindi Messmer, Kashvi Singh, Jennifer Cortes, Carrie Boan, Tarrin Weber, Danielle Hile, Nadine A. Kasparian, Rohan D'Souza, Melissa Russo, et al.


  • Prognostic Significance of Hemodynamics in Patients With Transposition of the Great Arteries and Systemic Right Ventricle

    by Nael Aldweib, Payam Dehghani, Craig S. Broberg, Alexandra van Dissel, Ahmad Altibi, Joshua Wong, David Baker, Salil Gindi, Paul Khairy, Alexander R. Opotowsky, et al.

    BACKGROUND: Patients with transposition of the great arteries (TGA) and systemic right ventricle often confront significant adverse cardiac events. The prognostic significance of invasive hemodynamic parameters in this context remains uncertain. Our hypothesis is that the aortic pulsatility index and hemodynamic profiling utilizing invasive measures provide prognostic insights for patients with TGA and a systemic right ventricle. METHODS: This retrospective multicenter cohort study encompasses adults with TGA and a systemic right ventricle who underwent cardiac catheterization. Data collection, spanning from 1994 to 2020, encompasses clinical and hemodynamic parameters, including measured and calculated values such as pulmonary capillary wedge pressure, aortic pulsatility index, and cardiac index. Pulmonary capillary wedge pressure and cardiac index values were used to establish 4 distinct hemodynamic profiles. A pulmonary capillary wedge pressure of ≥15 mm Hg indicated congestion, termed wet, while a cardiac index 2 signified inadequate perfusion, labeled cold. The primary outcome comprised a composite of all-cause death, heart transplantation, or the requirement for mechanical circulatory support. RESULTS: Of 1721 patients with TGA, 242 individuals with available invasive hemodynamic data were included. The median follow-up duration after cardiac catheterization was 11.4 (interquartile range, 7.5–15.9) years, with a mean age of 38.5±10.8 years at the time of cardiac catheterization. Among hemodynamic parameters, an aortic pulsatility index P P <0.001). CONCLUSIONS: A low aortic pulsatility index (<1.5) and the cold/wet hemodynamic profile are linked with an elevated risk of adverse long-term cardiac outcomes in patients with TGA and systemic right ventricle.


  • Open Access

    Long-term myocardial performance of the systemic right ventricle during exercise in patients with transposition of the great arteries and atrial switch operation

    by Urszula Alicja Kozicka, Katarzyna Kożuch, Krzysztof Sadowski, Tripti Gupta, Piotr Hoffman, Piotr Szymański, Mirosław Kowalski, Magdalena Lipczyńska

  • Open Access

    In-hospital mortality and length of stay among patients with infective endocarditis and solid organ transplant: A study from National Inpatient Sample 2016–2019

    by Nischit Baral, Annabelle Santos Volgman, Tripti Gupta, Arvind Kunadi, Mahin R. Khan, Soumya Kambalapalli, Hameem U. Changezi, Melissa Tracy


  • Open Access

    Pulmonary vein isolation after partial pulmonary vein repair in patient with heterotaxy, anomalous right pulmonary veins and atrial fibrillation with associated cardiomyopathy

    by Tripti Gupta, Adil Yousuf, Francis Benn, A. E. Hiltbold, Daniel Morin, Paul Rogers, Glenn Polin, Sammy Khatib, Walter Hoyt, Patricia Thomas, et al.

    Partial anomalous pulmonary venous connection (PAPVC) is an unusual congenital anomaly with variable sites of attachment of the atypical pulmonary veins. Anomalous right pulmonary vein return can be surgically corrected if left to right shunt physiology becomes hemodynamically significant. In such patients, as in the general population, the development of arrhythmia-associated heart failure due to atrial fibrillation prompts consideration of pulmonary vein isolation. There are limited reports of pulmonary vein isolation on surgically repaired PAPVC. This case highlights successful isolation of surgically corrected right pulmonary veins in a patient with PAPVC and atrial fibrillation associated heart failure.